Von Willebrand Disease (VWD)
Part 2: NHLBI Diagnosis Guidelines
Click CC to turn on closed captioning.
Von Willebrand disease (VWD) is a commonly encountered inherited bleeding disorder that affects both males and females. It may also occur less frequently as an acquired disorder (acquired von Willebrand syndrome: AVWS). A published evidence-based guideline from the National Heart, Lung, and Blood Institute (NHLBI) expert panel outlines recommendations for the evaluation and management of VWD, including suggesting an approach for clinical and laboratory evaluation of individuals with bleeding symptoms, history of bleeding or conditions associated with increased bleeding risk.
This is the second in a four-part series on von Willebrand disease, and is also included in the series on test utilization.
- Dr. William L. Nichols of the Division of Hematopathology
The von Willebrand Disease (VWD) Series
- Hot Topic: Von Willebrand Disease (VWD) Part 1: NHLBI Diagnosis Guidelines
- Hot Topic: Von Willebrand Disease (VWD) Part 2: NHLBI Diagnosis Guidelines
- Hot Topic: Von Willebrand Disease (VWD) Part 3: VWF Activity Assay
- Hot Topic: Von Willebrand Disease (VWD) Part 4: VWF Multimer Analysis
- von Willebrand Profile
- von Willebrand Factor Multimer Analysis, Plasma
- von Willebrand Factor Antigen, Plasma
- von Willebrand Factor Activity, Plasma
- Coagulation Factor VIII Activity Assay, Plasma
- von Willebrand Disease 2N (Subtype Normandy), Blood
Forward to a Colleague
Share this presentation with:
If you have questions, e-mail